Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash provided by (used for) operating activities
Net income (loss)	$ 493	$ 314
Depreciation and amortization	304	285
Deferred and prepaid income taxes	31	19
Stock-based compensation expense	63	55
Net loss (gain) on investments and notes receivable	2	31
Contingent consideration net expense (benefit)	17	12
Other, net	(4)	(2)
Trade accounts receivable	(114)	(86)
Inventories	(124)	(185)
Other assets	(55)	(41)
Accounts payable, accrued expenses and other liabilities	(450)	(211)
Cash provided by (used for) operating activities	164	190
Investing activities:
Purchases of property, plant and equipment and internal use software	(179)	(111)
Proceeds from sale of property, plant and equipment	1	3
Payments for acquisitions of businesses, net of cash acquired	(47)	(375)
Payments for investments and acquisitions of certain technologies, net of investment proceeds	(66)	(10)
Proceeds from royalty rights	7	9
Cash provided by (used for) investing activities	(285)	(484)
Financing activities:
Payment of contingent consideration previously established in purchase accounting	(34)	(34)
Payments for royalty rights	(15)	(34)
Payments for finance leases	(25)	0
Payments on short-term borrowings	(504)	0
Proceeds from long-term borrowings, net of debt issuance costs	2,145	0
Cash dividends paid on preferred stock	0	(14)
Cash used to net share settle employee equity awards	(78)	(50)
Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans	80	63
Cash provided by (used for) financing activities	1,569	(69)
Effect of foreign exchange rates on cash	(7)	0
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	1,441	(363)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	1,055	1,126
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	2,496	763
Supplemental Information
Stock-based compensation expense	63	55
Non-cash impact of transferred royalty rights	(7)	(9)
Cash and cash equivalents	2,329	570
Restricted cash and restricted cash equivalents included in Other current assets	93	135
Restricted cash equivalents included in Other long-term assets	74	57
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	$ 2,496	$ 763